Your shopping cart is currently empty

SL-3-19 is a tubulin ligand that exhibits antitumor activity against esophageal squamous cell carcinoma (ESCC) both in vitro and in vivo. It functions by inhibiting microtubule assembly, inducing G2/M phase cell cycle arrest and apoptosis, and disrupting tumor vasculature. SL-3-19 is more potent than SL-1-73 and can be utilized in research involving ESCC and similar tumors.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | SL-3-19 is a tubulin ligand that exhibits antitumor activity against esophageal squamous cell carcinoma (ESCC) both in vitro and in vivo. It functions by inhibiting microtubule assembly, inducing G2/M phase cell cycle arrest and apoptosis, and disrupting tumor vasculature. SL-3-19 is more potent than SL-1-73 and can be utilized in research involving ESCC and similar tumors. |
| Molecular Weight | 413.45 |
| Formula | C20H19N3O5S |
| Cas No. | 2000199-45-9 |
| Smiles | O=S(=O)(NC1=CC=C(N=C1OC)OC)C2=CC=C3C(=C2)C=4C=CC(O)=CC4N3C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.